Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Pain Practice : the Official Journal of World Institute of Pain|January 21, 2015
Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled TrialsAaron Yarlas, Kate Miller, Warren Wen, et al.
The Clinical Journal of Pain|January 8, 2014
The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and healthKate Miller, Aaron Yarlas, Warren Wen, et al.
Postgraduate Medicine|December 20, 2014
Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
The Journal of Pain|December 4, 2012
A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back painAaron Yarlas, Kate Miller, Warren Wen, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 24, 2025
Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer's diseaseDeli Wang, Hana Florian, Shau-Yu Lynch, et al.
Clinical and Translational Science|January 10, 2026
Safety, Tolerability, and Pharmacokinetics of Single Doses of ABBV-916, an Anti-Amyloid Antibody, in Healthy ParticipantsSagar S Bachhav, Hana Florian, Joey Boiser, et al.
Pain Practice : the Official Journal of World Institute of Pain|April 14, 2015
A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with DepressionAaron Yarlas, Kate Miller, Warren Wen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentShau Yu Lynch, Yamin Wang, Deli Wang, et al.
Pageof 2